Full Press Release Details
2026 Bloom Burton & Co. Healthcare Investor Conference "Targeting underlying causes of neurodegenerative diseases" Presented by Neil K. Warma CEO, ProMIS Neurosciences
Presented on 4/21/2026
PMN Positive Sentiment
Targeting underlying causes of neurodegenerative diseases | 2026 Bloom Burton & Co. Healthcare Investor Conference
Key Takeaway: Neil K. Warma, CEO of ProMIS Neurosciences, presented at the 2026 Bloom Burton & Co. Healthcare Investor Conference. The focus of the presentation was on addressing the underlying causes of neurodegenerative diseases, showcasing the company's commitment to innovative solutions in this critical area of healthcare.
Price reaction · baseline $11.08 (2026-04-27T14:29:00.000Z) · hit during market hours · clean, no other PMN news in the window
day 0 close · peak
+0.2%
Market Sentiment Analysis
POSITIVE FACTORS
- Focus on neurodegenerative diseases shows commitment to innovative solutions.
- Presentation by a CEO indicates strong leadership and vision.
- Engagement at a healthcare investor conference highlights investor interest.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+19%
120-day peak, hindsight
Typical move
14.5%
average across 3 past catalysts
Cash runway
~14 mo
Low dilution risk
Lead asset
PMN310
Phase 1 · Alzheimer Disease, Early Onset
Frequently Asked Questions
Who presented at the 2026 Bloom Burton conference?
Neil K. Warma, CEO of ProMIS Neurosciences, presented at the conference.
What was the focus of the presentation?
The presentation focused on targeting the underlying causes of neurodegenerative diseases.
When did the conference take place?
The 2026 Bloom Burton & Co. Healthcare Investor Conference took place on April 21, 2026.
What company is Neil K. Warma associated with?
Neil K. Warma is the CEO of ProMIS Neurosciences.